Methods of treatment of a BCL-2 disorder using BCL-2 antisense oligomers

Details for Australian Patent Application No. 2001288373 (hide)

Owner Genta Incorporated

Inventors Klem, Robert E.; Warrel Jr., Raymond P.; Fingert, Howard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001288373

PCT Pub. Number WO02/17852

Priority 60/237,009 29.09.00 US; 60/227,970 25.08.00 US; 09/709,170 10.11.00 US

Filing date 23 August 2001

Wipo publication date 13 March 2002

Acceptance publication date 11 May 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

11 May 2006 Application Accepted

  Published as AU-B-2001288373

7 September 2006 Standard Patent Sealed

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288374

2001288372